Response to the inquiry letter on abnormal fluctuations in stock trading
Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice
An indicative announcement by Hainan Huluwa Pharmaceutical Group Co., Ltd. on changes in the equity of shareholders holding 5% or more of the shares
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the results of shareholders holding 5% or more of the shares reduced their holdings
Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Response to the inquiry letter on abnormal fluctuations in stock trading
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the progress of capital increase for wholly-owned subsidiaries through debt-for-share swaps
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the progress of the financial leasing business of the company and its subsidiaries
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving government subsidies
Meeting materials of the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on providing guarantees for project loans for holding subsidiaries
Announcement of the Third Interim Resolution of the Third Board of Supervisors of Hainan Huluwa Pharmaceutical Group Co., Ltd. in 2024
Announcement of the fourth interim resolution in 2024 of the third board of directors of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the change of accounting firm
Notice of Hainan Huluwa Pharmaceutical Group Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining an oseltamivir phosphate capsule drug registration certificate
CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on Hainan Huluwa Pharmaceutical Group Co., Ltd. changing some fund-raising investment projects
No Data
No Data